PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'School of Medicine, Zhejiang University City College, Hangzhou, 310015, Zhejiang, China.\', \'Life Sciences Institute and Innovation Center for Cell Signaling Network, Zhejiang University, Hangzhou, Zhejiang 310058, China.\', \'Department of Orthopaedic Surgery, The Third Affiliated Hospital of Wenzhou Medical University, Rui\'an, China.\', \'Institutes of Biology and Medical Science, Soochow University, Suzhou 215123, China.\', \'Life Sciences Institute and Innovation Center for Cell Signaling Network, Zhejiang University, Hangzhou, Zhejiang 310058, China. zhanglong.2003@tsinghua.org.cn.\', \'Institutes of Biology and Medical Science, Soochow University, Suzhou 215123, China. zhoufangfang@suda.edu.cn.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41392-021-00796-w
?:hasPublicationType
?:journal
  • Signal transduction and targeted therapy
is ?:pmid of
?:pmid
?:pmid
  • 34753918
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • The way of SARS-CoV-2 vaccine development: success and challenges.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34753918>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34753918>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all